ABOUT NINGKE

NINGKE

Be a driver of China's synthetic biology industry.


Company Profile

Image name

The company is listed on the Shanghai Stock Exchange.

1998 Est.
Image name

Total land area of the company

750 mu+
Image name

The company currently has more than 500 employees.

500 person+
Image name

Holds various domestic and international patents.

20 item+

Ningxia Zhongke Biotechnology Co., Ltd.

Hereinafter referred to as the "Company" or "NINGKE".

Stock code:

600165


The company’s predecessor was Ningxia Hengli Steel Wire Rope Co., Ltd.Listed on the Shanghai Stock Exchange on May 29, 1998, marking the start of its journey toward capitalization and development.In 2017, the company’s strategic transformation focused on the field of biomanufacturing. We successfully introduced third-generation lauric acid production technology—developed by the Institute of Microbiology, Chinese Academy of Sciences, and possessing independent intellectual property rights—and built a 50,000-ton-per-year lauric acid production facility in the Shizuishan Economic and Technological Development Zone in Ningxia. Thanks to its technological innovation and industry-leading position, this project was successfully selected for the Chinese Academy of Sciences’ “Hongguang Special Program.”

The company is rooted in synthetic biology-based biomanufacturing and has established a diversified business portfolio as well as a well-rounded subsidiary operating system.Our business covers a range of long-chain dicarboxylic acids, bio-based food and health products, and animal feed, thus establishing a development model characterized by “core products leading and related industries collaborating.”

As a wholly-owned subsidiary of NINGKE and the core production base for long-chain dicarboxylic acids, Zhongke Xincai was established in June 2017. It covers a total area of 750 mu and currently employs over 500 people. Relying on its strong technological capabilities and standardized operational management, Zhongke Xincai has successfully been recognized as a “National High-Tech Enterprise.” Moreover, it has taken the lead in establishing two autonomous-region-level research platforms—the “Ningxia Bio-based Long-Chain New Materials Engineering Technology Research Center” and the “Ningxia Long-Chain Biomaterials Manufacturing Engineering Research Center”—thus building a comprehensive innovation system spanning from basic research and pilot-scale amplification to industrial-scale production. The company strictly adheres to quality control standards and has obtained GB/T19001-2016 quality management system certification. It currently holds nearly 20 independently owned intellectual property patents, with its core technologies ranking among the leading ones in China.

The company’s core product, long-chain dicarboxylic acid, is a green chemical new material that is strongly promoted by the Chinese government. It is produced using a biosynthetic process and, compared to conventional chemical synthesis methods, boasts significant advantages such as lower energy consumption, reduced pollution, higher product purity, and greater stability in performance. This product serves as a key raw material in the polyamide industry chain and is widely used in the production of high-end nylon, advanced fragrance intermediates, premium lubricants, highly effective rust inhibitors, environmentally friendly hot-melt adhesives, specialty synthetic fibers, and a host of other high-value-added chemical products. Its end-use applications span across multiple strategic emerging sectors, including automotive, electronics and electrical appliances, aerospace, high-end equipment, and military technology.

Relying on its core technologies and high-quality products, NINGKE has grown into a leading new materials enterprise that is being specially cultivated and supported by the Ningxia Hui Autonomous Region. It has also been included in the list of key backbone enterprises for the “9+3” specialized and characteristic industries in Shizuishan City, playing a pivotal role in regional industrial upgrading and green development. The company consistently regards long-chain dicarboxylic acid technology as its core driving force, continuously increasing R&D investment in downstream product series with high added value, and deeply cultivating the entire polyamide industry chain. It is fully committed to promoting the integrated development of the long-chain dicarboxylic acid industry system and its upstream and downstream linked industrial chains, thereby facilitating the large-scale application of bio-based long-chain polyamide materials in high-end fields and injecting new momentum into the high-quality development of the industry.

In the future, the company will firmly seize the strategic opportunities presented by the development of the synthetic biology industry during the 15th Five-Year Plan period. Upholding the corporate spirit of “self-reliance and relentless advancement, pursuing excellence,” and staying true to our original mission of “serving the country through industry and promoting green development,” we will take “improving industrial quality and fostering green development” as our guiding principle. We will simultaneously emphasize both R&D and production, as well as innovation and empowerment.The company will continue to strengthen its independent innovation capabilities in core technologies, constantly expand its upstream and downstream collaborative ecosystem, precisely align with market demands, and wholeheartedly move toward high-end, large-scale, and specialized development. We are committed to becoming a domestically leading and internationally renowned bio-manufacturing enterprise, working in synergy with partners across the industrial chain to jointly build a new paradigm of green manufacturing and high-quality development..

Development History


2025
As the industrial investor in the company’s restructuring plan, KYF completed the transfer of shares from capital surplus to the investor’s account on December 15, 2025. Following this share transfer, KYF holds 357 million shares of the company, representing 22.10% of the company’s total issued share capital.
KYF has officially become the company’s controlling shareholder, and Mr. Liu Xirong is the company’s actual controller.
2017
In the same year, the company divested its metal products business and related assets. Also in that year, it introduced a large-scale production technology for lauric acid, developed by the Institute of Microbiology, Chinese Academy of Sciences, which boasts independent intellectual property rights. Subsequently, the company established a subsidiary, Zhongke Xincai, in the Shizuishan Economic and Technological Development Zone in Ningxia, to build a lauric acid project with an annual capacity of 50,000 tons.
2015
On May 18, 2015, the company received a notice from the Registration and Settlement Company regarding the judicial freeze and judicial transfer of equity interests. The 80 million shares of Shanghai Xinri, which had been subject to judicial auction, have now been transferred to Shanghai Zhongneng, making Shanghai Zhongneng the company’s largest shareholder.
2011
On July 7, 2011, the company issued 80 million shares in a non-public offering to Shanghai Xinri. Following the completion of the issuance, Shanghai Xinri became the company’s largest shareholder, holding 29.20% of the company’s total share capital. This marked the company’s transition from state-owned control to private ownership.
2006
According to the “Administrative Measures for the Shareholding Structure Reform of Listed Companies” issued by the China Securities Regulatory Commission, in February 2006, the company achieved full circulation of its shares by reducing the shareholdings of non-tradable shareholders through debt-to-equity swaps and increasing the capital stock from the reserve fund allocated to tradable shareholders.
2003
On May 12, 2003, Hengli Group transferred its 29.46% state-owned shares in the company to Ningxia Electric Power Investment Co., Ltd., making Ningxia Electric Power Investment the company’s largest shareholder and Hengli Group the second-largest shareholder.
1998
NINGKE, formerly known as Ningxia Hengli Steel Wire Rope Co., Ltd., was listed on the Shanghai Stock Exchange on May 29, 1998, becoming China's first publicly listed steel wire rope company.

2025

2017

2015

2011

2006

2003

1998

Corporate culture


Image name

Corporate Vision

Become a globally leading and respected value creator in the field of bio-manufacturing based on synthetic biology technologies.

Image name

Corporate Mission

Through innovative technologies and outstanding operations, we provide customers with high-quality products and services, create a platform for our employees, deliver returns to our shareholders, and make positive contributions to society.

Image name

Core Values

Customer first, integrity and responsibility, pursuit of excellence, collaborative innovation, people-oriented.

Image name

Corporate Spirit

Self-reliance and striving forward, pursuing excellence.

Image name

Business Philosophy

Green Intelligent Manufacturing—Empowering the Ecosystem; Quality as the Foundation—Trusted at Our Core; Innovation-Driven—Leading the Way to Upgrades; Value Co-creation—Achieving Win-Win Development.

Image name

Core positioning

With synthetic biology technology at its core, we focus on the core business of bio-manufacturing long-chain dicarboxylic acids. Guided by the business philosophy of "green intelligent manufacturing, quality-driven foundation, innovation-driven, and value co-creation," we are committed to becoming a globally leading supplier of green bio-based materials, empowering industrial upgrades and sustainable development.

Honors and Qualifications


Relying on its strong technological R&D capabilities and standardized operational management system, Zhongke Xincai has successfully been recognized as a “National High-Tech Enterprise” and has taken the lead in establishing several autonomous-region-level scientific research and innovation platforms—including the “Ningxia Bio-based Long-Chain New Materials Engineering Technology Research Center,” the “Ningxia Long-Chain Bio-manufacturing Materials Engineering Research Center,” the “Ningxia Bio-based Materials Engineering Manufacturing Innovation Center,” and the “Ningxia Small Highland for Talent Development in the R&D of Long-Chain Dibasic Acid Bio-new Materials.” These platforms have helped build a comprehensive innovation ecosystem spanning the entire chain—from basic R&D and pilot-scale amplification to industrial-scale production.

The company has consistently adhered to stringent quality control standards and successfully obtained GB/T19001-2016 certification for its quality management system. To date, the company has accumulated nearly 20 patents with independent intellectual property rights, and its core technical indicators have reached a domestically leading level, providing a solid foundation for the company’s high-quality development.

Image name
20 Item+

Has patents with independent intellectual property rights